Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial
- 1 June 2014
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 73 (6) , 1123-1129
Abstract
Objectives The aims of this study were to investigate the influence of alendronate and intra-articular betamethasone treatment on bone mineral density (BMD) changes in hand, lumbar spine and femoral neck during 1 year of a treat-to-target study (Cyclosporine, Methotrexate, Steroid in RA (CIMESTRA)). Patients and methods A hundred and sixty patients with early, active rheumatoid arthritis (RA) received methotrexate, intra-articular betamethasone and ciclosporin /placebo-ciclosporin. Patients with Z-score ≤0 also started alendronate 10 mg/day. BMD of the hand (digital x-ray radiogrammetry (DXR-BMDhand)), BMD of lumbar spine and femoral neck (dual x-ray absorptiometry (DXA-BMDlumbar spine and DXA-BMDfemoral neck)) and x-rays of hands, wrists and forefeet (modified Sharp-van der Heijde score) were measured at baseline and 1 year, with complete data available in 107 patients. Results The change in BMD in hand, lumbar spine and femoral neck was negatively associated with the dose of intra-articular betamethasone (phand, which averaged −2.8%, whereas significant changes were observed in DXA-BMDlumbar spine and DXA-BMDfemoral neck in alendronate-treated patients (1.8% and 0.8%) compared with untreated patients (–1.8% and –2.2%) (pConclusions In early active RA, intra-articular betamethasone injections added to disease-modifying antirheumatic drug (DMARD) treatment led to minimal loss of hip and lumbar BMD, and the loss could be prevented by treatment with alendronate. Alendronate treatment did not affect radiographic progression.Keywords
This publication has 29 references indexed in Scilit:
- Effect of intra-articular corticosteroid injections and inflammation on periarticular and generalised bone loss in early rheumatoid arthritisAnnals of the Rheumatic Diseases, 2011
- Osteoclasts and ArthritisJournal of Bone and Mineral Research, 2009
- Reduced Loss of Hand Bone Density With Prednisolone in Early Rheumatoid ArthritisArchives of internal medicine (1960), 2005
- Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor–mediated arthritisArthritis & Rheumatism, 2004
- Effects of bisphosphonates on joint damage and bone loss in rat adjuvant-induced arthritisInflammation Research, 2004
- Bone loss in unclassified polyarthritis and early rheumatoid arthritis is better detected by digital x ray radiogrammetry than dual x ray absorptiometry: relationship with disease activity and radiographic outcomeAnnals of the Rheumatic Diseases, 2004
- Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implicationsArthritis Research & Therapy, 2000
- Alendronate for the Prevention and Treatment of Glucocorticoid-Induced OsteoporosisNew England Journal of Medicine, 1998
- Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritisThe Lancet, 1997
- Longitudinal study of hand bone densitometry in rheumatoid arthritisArthritis & Rheumatism, 1995